Kestra reported $95.1 million in FY26 revenue, up 59%, alongside expanded margins and $137 million in guidance. This strong performance highlights the company's market leadership in wearable defibrillator systems and robust financial path ahead.
Kestra reported $95.1 million in FY26 revenue, up 59%, alongside expanded margins and $137 million in guidance. This strong performance highlights the company's market leadership in wearable defibrillator systems and robust financial path ahead.